Logo

International Journal of Cancer Care and Delivery

article

Vol. 5, Issue Supplement 1, 2025

(S1-169)

Abstracts from the Summit on Cancer Health Disparities 2025

Conference Abstracts

Facial Swelling and Dyspnea as Presenting Symptoms for Non-Hodgkin’s Lymphoma

Linda Chang

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Cabozantinib for PDGFRB Mutant High-Grade Uterine Sarcoma: A Precision Oncology Case Report

Austine Peng, Nicholas Ladwig, Jessica Van Ziffle, Deepika Sirohi, Kiauntee Murray, Varun Monga

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Emergence of ALK Fusion Following RET TKI Therapy in NSCLC: Evidence of Bypass Resistance

Aliya Lackan, Rohan Gupta, John Mathew

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis

Amy Huang, Gin Yi Lee, Chuan Angel Lu, Ibrahim Halil Sahin, Gentry T. King, Rachael A. Safyan, Stacey A. Cohen, David B. Zhen, Veena Shankaran, William P. Harris, Andrew L. Coveler, Jyoti Malhotra, Victoria E. Forbes, Philip J. Gold, E. Gabriela Chiorean, Ronan W. Hsieh

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Rapid, Reproducible, Rare Cell 3D Expansion (R3CE®) of CTC spheroids from peripheral whole blood from patients with metastatic solid tumors

Yung-Hao Lin, Aurin Liu, Ange Bair, Jia-Yang Chen, Ying-Chih Chang, Mark D. Pegram

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Ph-like ALL Exhibits Unique Hematological Features with CD36 Overexpression: A Diagnostic and Prognostic Analysis of 1,021 Indian Patients.

Dikshat Gopal Gupta, Monika Fnu, Aarohan Puri, Praveen Sharma, Man Updesh Singh Sachdeva, Shano Naseem, Parveen Bose, Jogeshwar Binota, Pankaj Malhotra, Alka Khadwal, Subhash Varma

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Sustained Response to Avapritinib in Uterine Sarcoma with a PDGFRA D842V Mutation

Sukjun Lee, Nam Bui, Walter Devine, Varun Monga

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Response to Tyrosine Kinase Inhibitors in Patients with BCR-ABL1 Positive Chronic Myeloid Leukemia; 20 Years’ Experience at Patan Hospital, Nepal

Nabina Thapa

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Race/ethnicity associated clinicogenomic, socioeconomic, and environmental predictors in metastatic non-small cell lung cancer (mNSCLC) treated with immunotherapy

Nirosha Perera King, Lingzhi Hong, Dawen Sui, Waree Rinsurongkawong, Elliana Young, Mehmet Altan, John Lin, Jianjun Zhang

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Integrative Oncology as a Bridge to Cell Therapy: An N-of-1 Case Study in Dendritic Cell Double Loading and following the CAR-T down the road to Bispecific Era Support

David James

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

A case of incidental detection of Waldenstrom macroglobulinemia following multi-cancer early detection testing

Jamie Abad, Tasnim Rahman, Philip Kuriakose, Joshua Collins

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Utilization and Timing of First Tumor Next-generation Sequencing Testing (NGS) in Patients with Five Most Common Cancers in the USA

Zeynep Irem Ozay, Yeonjung Jo, Chadi Hage Chehade, Micah Ostrowski, Nicolas Sayegh, Georges Gebrael, Tanner Hardy, Edwin Lin, Richard Ji, Roberto Nussenzveig, Ayana Srivastava, Vinay Mathew Thomas, Sumati Gupta, Benjamin Maughan, Neeraj Agarwal, Umang Swami

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Comprehensive genomic profiling (CGP) of advanced cancer patients undergoing care within a large, community setting health plan

Sachdev Thomas, Habel Laurel, Ninah Achacoso, Elaine Chung, Chen Jiang, Jin Mei, Pam Tse, Aleyda Solarzano Pinto, Lori Sakoda, Tilak Sundaresan, J.Marie Suga

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Prognostic value of Nectin-4 and Trop2 extracellular vesicles for plasma and urine samples collected from patients with bladder cancer just prior to cystectomy

Albert Jang, Yohan Kim, Emily Bauer, Prabin Thapa, Igor Frank, Paras Shah, John Cheville, Jacob Orme, Fabrice Lucien

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference Abstracts

Clinico-genomic Characterization of PALB2-Mutated Pancreatic Adenocarcinoma

Jonathan Lee, Catherine O'Connor, Emily Harrold, Allison Richards, Florencia Velez-Cortes, Drew Moss, Joshua Schoenfeld, Anupriya Singhal, Rohit Thummalapalli, Carly Schwartz, Brinda Alagesan, Mary Larsen, Fiyinfolu Balogun, Anna Varghese, Kenneth Yu, David Kelsen, Wungki Park, Diana Mandelker, Zsofia Stadler, Eileen O'Reilly

Abstract from the 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Scroll for more
IJCCD AI Assistant